Clinical Trials Browser

Phase 2 × deucravacitinib × 30 days × Clear all

NCT07335796 2026-03-13

A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms